EN PL
CASE REPORT
Osteolytic lesions in the pelvis of the patient with an aggressive form of psoriatic arthritis
 
More details
Hide details
 
Online publication date: 2012-03-02
 
 
Reumatologia 2012;50(1):57-60
 
KEYWORDS
ABSTRACT
Psoriatic arthritis (PsA) is a chronic, inflammatory disease. It occurs in 6 to 42% of patients suffering from psoriasis. The cause of both PsA and psoriasis is still unknown. In progressing PsA synovitis, bone erosion, osteolysis (distal phalanges, distal epiphysises of forearm and carpus bones) and new bone formation can be observed. PsA results in destructive abnormalities as well as simultaneous proliferation. The incidence of osteolytic abnormalities in iliac bone is not a typical sign of PsA. In the paper the case of a 48-year-old man, who was diagnosed with PsA 10 years earlier is presented. The patient was treated irregularly. There occured disease exacerbation, progressing devastation, decline in body mass, high inflammatory degree and osteolytic abnormalities in iliac bones that are usually associated with cancer. A wide imaging diagnosis had been carried out (KT of chest, KT of abdominal cavity, scintigraphy, PET), which did not confirm cancer development. Due to the lack of improvement during treatment with disease modifying drugs (methotrexate, cyclosporine), was decided to include biological agents for the treatment of anti TNF-α (infliximab, adalimumab).
REFERENCES (21)
1.
Gladman D, Brockmank J. Psoriatic arthritis. Expert Opin Investig Drugs 2000; 9: 1511-1522.  .
 
2.
Gladman D, Antoni C, Mease P, et al. Psoriatic arthritis and psoriasis: classification, clinical features, pathophysiology, immunology, genetics. Ann Rheum Dis 2005; 64: 14-17.  .
 
3.
Przepiera-Będzak H, Brzosko M. Łuszczycowe zapalenie stawów. W: Wielka Interna, t. 9, Puszczewicz M (red.). Medical Tribune, Warszawa 2010; 259-264.  .
 
4.
Nograles KE, Brasington RD, Bowcock AM. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol 2009; 5: 83-91.  .
 
5.
Pattison E, Harrison BJ, Grffiths CE, et al. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008; 67: 672-676.  .
 
6.
Mease PJ, Helliwel PS. Atlas of Psoriatic Arthritis. Springer, London 2008.  .
 
7.
Myers A, Kay LJ, Lynch SA, et al. Recurrence risk for psoriasis and psoriatic arthritis within sibships. Rheumatology 2005; 44: 773-776.  .
 
8.
Coca A, Ritchlin CT. Psoriatic arthritis: A disease in full. J Musculoskeletal Med 2011; 28: 95-101.  .
 
9.
Dalbeth N, Pool B, Smith T, et al. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther 2010; 12: R164. .
 
10.
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Curr Rheumatol Rep 2008; 10: 311-317. .
 
11.
Strauss EJ, Alfonso D, Baidwan G, et al. Orthopedic manifestations and management of psoriatic arthritis. Am J Orthop 2008; 37: 138-147. .
 
12.
Zimmermann-Górska I, Szechiński J, Kwiatkowska B. Zapalenia stawów z zajęciem stawów kręgosłupa. W: Choroby wewnętrzne. Szczeklik A. (red.). Medycyna Praktyczna, Kraków 2011; 1795-1811. .
 
13.
Pipitone N, Kingsley GH, Manzo A, et al. Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology 2003; 42: 1138-1148. .
 
14.
Drosik K, Krzakowski M, Jarosz J i wsp. Bisfosfoniany w zapobieganiu i kontroli zdarzeń kostnych u chorych z przerzutami nowotworów złośliwych do kości. Onkologia w Praktyce Klinicznej 2006; 4: 152-164. .
 
15.
Ozulker T, Kucukoz Uzun A, Ozulker F, et al. Comparison of (18)F- FDG-PET/CT with (99m) Tc-MDP bone metastases in cancer patients. Nukl Med Commun 2010; 31: 597-603. .
 
16.
Matryba M, Wisłowska M. Zastosowanie scyntygrafii w reumatologii. Reumatologia 2009; 47: 290-299. .
 
17.
Ritchlin CH, Hellwell P. Psoriatic Arthritis: From Leeds to the Limelight. www.the- rheumatologist.org. .
 
18.
Tan AL, McGonagle D. Psoriatic arthritis: correlation between imaging and pathology. Joint Bone Spine 2010; 77: 206-211. .
 
19.
Przepiera-Będzak H, Brzosko I. Zespół SAPHO. W: Wielka interna, t. 9, Puszczewicz M (red.). Medical Tribune, Warszawa 2010; 268-270. .
 
20.
Zielińska A, Rupiński R, Filipowicz-Sosnowska A. Zespół SAPHO – odmienność przebiegu – trudności diagnostyczne. Reumatologia 2006; 44: 213-219. .
 
21.
Filipowicz-Sosnowska A. Skrobiawica. W: Reumatologia kliniczna. Zimmermann-Górska I (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2008; 837-842.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top